mibefradil has been researched along with tacrolimus in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Gallino, A; Giostra, E; Krähenbühl, S; Menafoglio, A | 1 |
| Lochs, H; Mai, I; Ocran, KW; Plauth, M | 1 |
4 other study(ies) available for mibefradil and tacrolimus
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Roche, FDA announce new drug-interaction warnings for mibefradil.
Topics: Anticholesteremic Agents; Benzimidazoles; Calcium Channel Blockers; Contraindications; Cyclosporine; Drug Interactions; Drug Labeling; Humans; Immunosuppressive Agents; Mibefradil; Tacrolimus; Tetrahydronaphthalenes; United States; United States Food and Drug Administration | 1998 |
Serious interaction between mibefradil and tacrolimus.
Topics: Benzimidazoles; Calcium Channel Blockers; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Female; Humans; Hypertension; Immunosuppressive Agents; Liver Transplantation; Mibefradil; Middle Aged; Tacrolimus; Tetrahydronaphthalenes | 1998 |
Tacrolimus toxicity due to drug interaction with mibefradil in a patient after liver transplantation.
Topics: Antihypertensive Agents; Calcium Channel Blockers; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Metabolic Clearance Rate; Mibefradil; Middle Aged; Tacrolimus | 1999 |